If you liked this article you might like

Trump's FDA: A Friendlier Biotech Sheriff
Arena Pharma's Stock Could Still Double Even After Tuesday's Epic Run
Why I Hate the FAANGs (but Like Banks and Biotech) for 2017's Second Half
3 Fearless Predictions for the Second Half